Region Stockholm’s stated goal is to make Stockholm one of the five most prestigious and successful life sciences clusters in the world by 2023. KI has…
In Conversation
In general, our management team is more familiar with the European and US markets, but we are certainly not going to neglect the China market.
For the first time in the history of the island, we have the opportunity to take intellectual property from a university and use it for potential…
We believe that our medicines must be fairly priced and broadly accessible. Receiving reimbursement from the TLV was a straightforward process, because we applied at a…
The competitive spirit that makes operating on the island attractive is still present
Currently, I believe that we might be the only company in the world working in the area of ovine heparin
Companies expect incentives to be kept in place, regardless of which government is in place
Focusing on the right products for Thailand then working to ensure access has to be the priority for all players
Our ambition is to be the prime site for clinical research not only in Puerto Rico but also in the Southern part of the US
Almost everyone agrees that we can come further in a joint approach to HTA. It is about defining the space between traditional regulatory work and the…
At bioMérieux, we keep in mind that without challenges, no achievements are possible
Dafang Zhong – Director, Shanghai Center for Drug Metabolism and Pharmacokinetics Research, SIMM, CAS, China

In 2007, we worked on only six innovative compounds. Since 2015, however, we have worked on over 20 innovative drug compounds every year